Eli Lilly Q1 Total Revenue Up 9%
Eli Lilly has posted a net income of $1.25bn, or $1.13 per diluted share, a decrease of 5%, compared to $1.31bn, or $1.20 per diluted share, for the
The European Commission (EC) has granted orphan designation to Lundbeck’s investigational monoclonal antibody asedebart (Lu AG13909) for the treatment of Cushing’s syndrome of endogenous origin.
In addition to providing technology systems that help all pharmaceutical companies print Standardized Numerical Identification (SNI) codes on all secondary packaging, Covectra offers unit-dose identification technology that provides
Bioniche’s research activities are focused mainly on small-scale, bench-top experiments. In order to scale-up the associated processes, a facility is required that houses pilot-scale fermentation equipment and downstream